The Department of Pharmaceuticals has launched a production-linked incentive (PLI) scheme to promote domestic pharmaceutical drugs manufacturing.
The step has been taken in order to make the country self-reliant to a large extent in respect of pharmaceutical drugs by setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.
Accordingly, the Ministry of Chemicals and Fertilizers has informed that it has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under PLI scheme for active pharmaceutical ingredients. The government on 25th February 2021 also approved a PLI scheme for the pharmaceutical sector, entailing an outlay of Rs 15,000 crore.
However, the commercial production of these plants is projected to commence from 1st April, 2023, onward.
Click here for detailed official press release:
Knowledge Source:
Telecom Can Only Install Government Approved Gears from 15th June